Valuation: Becton, Dickinson and Company

Market Cap 42.76B 37.44B 34.57B 32.28B 60.76B 4,043B 62.14B 416B 161B 1,994B 161B 157B 6,925B P/E 2026 *
38.7x
P/E 2027 * 29.8x
Enterprise Value 58.72B 51.41B 47.46B 44.32B 83.43B 5,551B 85.33B 571B 220B 2,739B 221B 216B 9,508B EV / Sales 2026 *
3.06x
EV / Sales 2027 * 2.88x
Free-Float
74.04%
Yield 2026 *
2.48%
Yield 2027 * 2.52%
1 day-2.26%
1 week+7.96%
Current month+5.58%
1 month+5.58%
3 months-0.52%
6 months-19.07%
Current year-19.02%
1 week 130.5
Extreme 130.5
137.4
1 month 123.7
Extreme 123.7
140.65
Current year 122.3
Extreme 122.3
180.9
1 year 122.3
Extreme 122.3
180.9
3 years 122.3
Extreme 122.3
260.5
5 years 122.3
Extreme 122.3
263.5
10 years 122.3
Extreme 122.3
263.5
Manager TitleAgeSince
Chief Executive Officer 53 2020-01-27
Director of Finance/CFO 44 2025-12-04
Compliance Officer - 2023-01-31
Director TitleAgeSince
Director/Board Member 75 2002-09-23
Director/Board Member 71 2010-07-25
Chairman 53 2021-04-27
Change 5-day change 1-year change 3-year change Capi.($)
-2.26%+7.96% - - 42.96B
-1.50%+5.56%-31.01%-13.89% 164B
-0.06%+2.09%-5.92%-6.73% 104B
-1.57%+3.82%-5.93%+47.83% 55.67B
+0.27%-4.11%+50.77%+53.14% 52.92B
+1.90%+14.12% - - 32.87B
-0.23%+1.32%-18.94%-45.30% 27.07B
+1.09%+7.57%+62.05%-6.01% 24.79B
-1.13%+6.41%-10.70%-3.51% 21.02B
+0.42%+0.36%-15.00%-2.72% 20.18B
Average -0.33%+2.73%+3.17%+2.85% 55.79B
Weighted average by Cap. -0.66%+3.14%-6.06%+2.12%

Financials

2026 *2027 *
Net sales 19.21B 16.82B 15.52B 14.5B 27.29B 1,816B 27.91B 187B 72.12B 896B 72.12B 70.54B 3,110B 19.71B 17.26B 15.93B 14.88B 28.01B 1,864B 28.65B 192B 74.02B 919B 74.02B 72.4B 3,192B
Net income 1.12B 985M 909M 849M 1.6B 106B 1.63B 10.94B 4.22B 52.46B 4.22B 4.13B 182B 1.45B 1.27B 1.17B 1.09B 2.06B 137B 2.11B 14.1B 5.44B 67.59B 5.44B 5.32B 235B
Net Debt 15.95B 13.97B 12.9B 12.04B 22.67B 1,508B 23.19B 155B 59.91B 744B 59.92B 58.6B 2,584B 14.07B 12.32B 11.38B 10.62B 20B 1,330B 20.45B 137B 52.84B 656B 52.85B 51.69B 2,279B
Logo Becton, Dickinson and Company
Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical management systems (52.4%): medication delivery systems, pharmaceutical systems, advanced patient monitoring systems, etc.; - interventional medical equipment (23.9%): surgical instruments, urological care products, etc.; - diagnostic materials and clinical research and development tools (23.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, tools for studying genes and culturing cells, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (58.6%), Europe/Middle East/Africa (21.6%), Asia (14.2%) and other (5.6%).
Employees
72,000
Date Price Change
26-06-29 €134.30 -2.26%
26-06-26 €137.40 +2.92%
26-06-25 €133.50 +2.30%
26-06-24 €130.50 +3.57%
26-06-23 €126.00 +1.29%
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
155.19USD
Average target price
177.75USD
Spread / Average Target
+14.54%

Quarterly revenue - Rate of surprise